Ratings by B.Riley (Justin Walsh)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/17/2026 | Lantheus Holdings | LNTH | Downgrade | Neutral (Buy) |
100.95 (100.88) |
-0.07% | Details | |
| 7/29/2026 | Lantheus Holdings | LNTH | Maintain | Buy (N/A) |
|
Details | ||
| 7/9/2026 | Lantheus Holdings | LNTH | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2026 | Lantheus Holdings | LNTH | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2025 | Lantheus Holdings | LNTH | Maintain | Buy (N/A) |
|
Details | ||
| 6/23/2025 | Lantheus Holdings | LNTH | Maintain | Buy (N/A) |
|
Details | ||
| 3/21/2025 | Lantheus Holdings | LNTH | Maintain | Buy (N/A) |
|
Details | ||
| 7/25/2024 | Lantheus Holdings | LNTH | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2024 | Lantheus Holdings | LNTH | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2024 | Lantheus Holdings | LNTH | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2023 | Checkpoint Therapeutics | CKPT | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2022 | Checkpoint Therapeutics | CKPT | Maintain | Buy (N/A) |
|
Details | ||
| 8/25/2022 | Lantheus Holdings | LNTH | Maintain | Buy (N/A) |
|
Details | ||
| 7/14/2022 | Checkpoint Therapeutics | CKPT | New Coverage | Buy (N/A) |
1.08 (4.26) |
294.44% | Details | |
| 5/19/2022 | Harrow Health | HROW | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2022 | Lantheus Holdings | LNTH | New Coverage | Buy (N/A) |
64.15 (100.95) |
57.37% | Details | |
| 5/4/2022 | CytoSorbents | CTSO | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2022 | CytoSorbents | CTSO | Maintain | Buy (N/A) |
|
Details | ||
| 1/19/2022 | Compass Therapeutics | CMPX | New Coverage | Buy (N/A) |
2.76 (2.31) |
-16.3% | Details | |
| 1/11/2022 | ViewRay Inc. | VRAY | Upgrade | Buy (Neutral) |
4.96 (4.51) |
-9.07% | Details | |
| 10/14/2021 | CytoSorbents | CTSO | New Coverage | Buy (N/A) |
6.13 (0.34) |
-94.45% | Details | |
| 10/14/2021 | Harrow Health | HROW | New Coverage | Buy (N/A) |
10.19 (36.97) |
262.81% | Details | |
| 10/14/2021 | Eton Pharmaceuticals | ETON | New Coverage | Buy (N/A) |
5.43 (60.43) |
1012.89% | Details | |
| 10/14/2021 | ViewRay Inc. | VRAY | New Coverage | Buy (N/A) |
6.41 (0.03) |
-99.53% | Details | |
| 9/2/2021 | Portage Biotech inc. | PRTG | New Coverage | Buy (N/A) |
21.61 (6.81) |
-68.49% | Details | |
| 8/26/2021 | Fusion Pharmaceuticals | FUSN | New Coverage | Buy (N/A) |
8.31 (21.55) |
159.33% | Details | |
| 6/9/2021 | F-Star Therapeutics Inc. | FSTX | New Coverage | Buy (N/A) |
6.95 (7.12) |
2.45% | Details | |
| 6/9/2021 | Checkpoint Therapeutics | CKPT | New Coverage | Buy (N/A) |
2.66 (4.26) |
60.15% | Details | |
| 2/18/2021 | Syndax Pharmaceuticals | SNDX | New Coverage | Buy (N/A) |
21.26 (20.10) |
-5.46% | Details | |
| 2/18/2021 | Precigen Inc. | PGEN | New Coverage | Buy (N/A) |
8.07 (6.86) |
-14.99% | Details |
